Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2010) 21 P149

SFEBES2009 Poster Presentations Diabetes and metabolism (59 abstracts)

Intravitréal bevacizumab injection for proliferative diabetic retinopathy

Laayoun Jaouad , Mouzari Yassine & Douhal Abderrahman


HMMI Meknes, Meknes, Morocco.


Introduction: To report the efficacy and safety of intravitreal bevacizumab (avastin) as an adjunctive treatment for proliferative diabetic retinopathy (PDR).

Objectives and methods: Thirteen patients (13 eyes) with PDR underwent an intravitreal injection of 1.25 mg of bevacizumab. All patients underwent a complete ophthalmic examination, anterior segment or fundus photographs at baseline and after bevacizumab injection.

Results: Eleven patients (84%) showed complete regression of anterior segment retinal, and/or optic disc neovascularisation between 1 and 3 weeks after injection. Treatment was well tolerated and no complications were observed.

Discussion: Short-term results suggest that intravitreally administrated bevacizumab (avastin) for PDR is effective and safe.

Conclusion: Further studies are required to better assess the efficacy and safety of intravitreal bevacizumab as adjunctive treatment of PDR.

Article tools

My recent searches

No recent searches.